Cargando…
EGFL7 drives the evolution of resistance to EGFR inhibitors in lung cancer by activating NOTCH signaling
Accumulating evidence supports evolutionary trait of drug resistance. Like resilience in other systems, most tumor cells experience drug-tolerant state before full resistance acquired. However, the underlying mechanism is still poorly understood. Here, we identify that EGF like domain multiple 7 (EG...
Autores principales: | Wang, Yubo, Chen, Pu, Zhao, Man, Cao, Hongxin, Zhao, Yuelei, Ji, Meiju, Hou, Peng, Chen, Mingwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617940/ https://www.ncbi.nlm.nih.gov/pubmed/36309484 http://dx.doi.org/10.1038/s41419-022-05354-y |
Ejemplares similares
-
Disulfiram/Cu Kills and Sensitizes BRAF-Mutant Thyroid Cancer Cells to BRAF Kinase Inhibitor by ROS-Dependently Relieving Feedback Activation of MAPK/ERK and PI3K/AKT Pathways
por: Xie, Jingyi, et al.
Publicado: (2023) -
LncEGFL7OS regulates human angiogenesis by interacting with MAX at the EGFL7/miR-126 locus
por: Zhou, Qinbo, et al.
Publicado: (2019) -
EGFL7 reduces CNS inflammation in mouse
por: Larochelle, Catherine, et al.
Publicado: (2018) -
Egfl7 promotes tumor escape from immunity
por: Pinte, Sébastien, et al.
Publicado: (2012) -
Novel Expression of EGFL7 in Osteosarcoma and Sensitivity to Cisplatin
por: Liu, Qing, et al.
Publicado: (2020)